Dudediligence.

AtriCure, Inc

ATRCNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$4,386,713

17 notices · 106,034 sh

Oct 2025 to Oct 2026

Reported ·

$1,052,128

7 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 7 reported sales carry the 10b5-1 box. Together they are 0.06% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-23: SALVATORE PRIVITERA, Form 1442026-09-10: GROVES REGINA E, Form 1442026-09-08: SALVATORE PRIVITERA, Form 1442026-09-02: SALVATORE PRIVITERA, Form 1442026-08-24: KARL DAHLQUIST, Form 1442026-08-05: Prange Karen, Form 1442026-08-05: MAGGIE YUEN, Form 1442026-07-29: Noznesky Justin J, Form 1442026-07-28: VINAYAK DORAISWAMY, Form 1442026-07-28: SVEN WEHRWEIN, Form 1442026-05-20: Prange Karen, Form 1442026-05-15: VINAYAK DORAISWAMY, Form 1442026-03-12: VINAYAK DORAISWAMY, Form 1442025-11-26: Noznesky Justin J, Form 1442025-11-25: SVEN WEHRWEIN, Form 1442025-11-24: SVEN WEHRWEIN, Form 1442025-11-21: MAGGIE YUEN, Form 1442025-11-21: Yuen Maggie, sold2025-11-24: WEHRWEIN SVEN, sold2025-11-26: Noznesky Justin J, sold2026-03-12: Doraiswamy Vinayak, sold2026-05-15: Doraiswamy Vinayak, sold2026-05-20: Prange Karen, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-23SALVATORE PRIVITERA, Chief Technical Officer$271,140
4,519 shplan 2026-02-20Form 4s on file end Jun 23144 ↗
2026-09-10GROVES REGINA E, Director$285,096
5,313 shno plan dateForm 4s on file end Jun 23144 ↗
2026-09-08SALVATORE PRIVITERA, Chief Technical Officer$201,135
3,657 shplan 2026-02-20Form 4s on file end Jun 23144 ↗
2026-09-02SALVATORE PRIVITERA, Chief Technical Officer$407,558
7,763 shplan 2026-02-20Form 4s on file end Jun 23144 ↗
2026-08-24KARL DAHLQUIST, Chief Legal Officer$458,091
9,370 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-05Prange Karen, Director$138,996
3,564 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-05MAGGIE YUEN, Director$134,468
3,500 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-29Noznesky Justin J, Chief Mktg & Strategy Officer$239,882
6,182 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-28VINAYAK DORAISWAMY, Chief Scientific Officer$233,279
6,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-28SVEN WEHRWEIN, Director$964,444
25,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-20Prange Karen, Director$86,400
3,000 shno plan date144 ↗
Form 4, 2026-05-22: sold 3,000 at $28.65 Form 4 ↗
2026-05-15VINAYAK DORAISWAMY, Chief Scientific Officer$140,674
5,000 shno plan date144 ↗
Form 4, 2026-05-18: sold 5,000 at $28.13 Form 4 ↗
2026-03-12VINAYAK DORAISWAMY, Chief Scientific Officer$149,152
5,000 shno plan date144 ↗
Form 4, 2026-03-16: sold 5,000 at $29.83 Form 4 ↗
2025-11-26Noznesky Justin J, Chief Mktg & Strategy Officer$192,642
5,166 shno plan date144 ↗
Form 4, 2025-11-26: sold 5,166 at $37.29 Form 4 ↗
2025-11-25SVEN WEHRWEIN, Director$188,746
4,967 shno plan dateno Form 4 on file144 ↗
2025-11-24SVEN WEHRWEIN, Director$187,854
5,033 shno plan date144 ↗
Form 4, 2025-11-26: sold 10,000 at $37.66 Form 4 ↗
2025-11-21MAGGIE YUEN, Director$107,158
3,000 shno plan date144 ↗
Form 4, 2025-11-25: sold 3,000 at $35.72 Form 4 ↗